Main Article Content
SPTCL, CTCL, CHOP, T-CELL, METHOTREXATE
Subcutaneous panniculitis-like T-Cell lymphoma (SPTCL) is a rare subtype of cutaneous T-cell lymphoma, and it has been associated with a range of clinical symptoms from mild to severe. Most commonly, this disease is described as following a slowly progressing course, associated with vague constitutional symptoms and good prognosis. This case report describes the clinical presentation and findings of SPTCL in a 31 year old female and describes the challenges of recognizing and properly diagnosing this disease. SPTCL has been described as a mimicker of other, more common and nonmalignant diseases of the skin, such as lupus panniculitis. This report highlights a variety of specific tests including immunohistochemical and immunoperoxidase staining, as well as genotypic analysis of T-cell receptors, that were effective in combination in isolating this diagnosis. Moreover, choice of treatment for these patients can be challenging, as an array of interventions have been described in past cases to treat SPTCL. This report recognizes the efficacy of a treatment course that included a six-cycle course of combined chemotherapy (vincristine, doxurubicine, cyclophosphamide, and prednisone, also known as CHOP) followed by weekly methotrexate and PET scan surveillance for two years. With both initial and maintenance therapy, this patient showed excellence response evidenced by a progressive decrease in metabolic activity of malignant lesions, lack of new lesions, and remaining without symptoms. While this disease is rare, it is important to include SPTCL in the differential when considering patients with a panniculitic picture.
2. Schramm, N., et al., Subcutaneous panniculitis-like T-cell lymphoma with breast involvement: functional and morphological imaging findings. Br J Radiol, 2010. 83(989): p. e90-4.
3. Gonzalez, C.L., et al., T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol, 1991. 15(1): p. 17-27.
4. Sugeeth, M.T., et al., Subcutaneous panniculitis-like T-cell lymphoma. Proc (Bayl Univ Med Cent), 2017. 30(1): p. 76-77.
5. Chen, R., L. Liu, and Y.M. Liang, Treatment relapsed subcutaneous panniculitis-like T-cell lymphoma together HPS by Cyclosporin A. Hematol Rep, 2010. 2(1): p. e9.
6. Shen, G., L. Dong, and S. Zhang, Subcutaneous Panniculitis-like T Cell Lymphoma Mimicking Early-Onset Nodular Panniculitis. Am J Case Rep, 2016. 17: p. 429-33.
7. Bagheri, F., et al., An illustrative case of subcutaneous panniculitis-like T-cell lymphoma. J Skin Cancer, 2011. 2011: p. 824528.
8. Gorodetskiy, V.R., et al., Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography evaluation of subcutaneous panniculitis-like T cell lymphoma and treatment response. World J Clin Cases, 2016. 4(9): p. 258-63.
9. Gallardo, F. and R.M. Pujol, Subcutaneous panniculitic-like T-cell lymphoma and other primary cutaneous lymphomas with prominent subcutaneous tissue involvement. Dermatol Clin, 2008. 26(4): p. 529-40, viii.
10. Bolognia, J., Jorizzo, J. and Schaffer, J. , Dermatology. 2012, Philadephia: Elsevier Saunders.
11. Vijaya, B., M.D. Sunila, and G.V. Manjunath, Subcutaneous panniculitic-like T-cell lymphoma: a red alert! The role of a vigilant histopathologist. Indian J Pathol Microbiol, 2011. 54(2): p. 376-8.
12. Lozzi, G.P., et al., Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma. Am J Dermatopathol, 2006. 28(1): p. 9-12.
13. Francis, A., et al., Subcutaneous panniculitis-like T-cell lymphoma. Indian J Dermatol, 2010. 55(3): p. 290-2.
14. Iqbal, N. and V. Raina, Successful treatment of disseminated subcutaneous panniculitis-like T-cell lymphoma with single agent oral cyclosporine as a first line therapy. Case Rep Dermatol Med, 2014. 2014: p. 201836.
15. Sakurai, E., et al., Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with hemophagocytosis (HPS): successful treatment using high-dose chemotherapy (BFM-NHL & ALL-90) and autologous peripheral blood stem cell transplantation. J Clin Exp Hematop, 2013. 53(2): p. 135-40.
16. Kitayama, N., et al., CCR4 and CCR5 expression in a case of subcutaneous panniculitis-like T-cell lymphoma. Eur J Dermatol, 2017. 27(4): p. 414-415.
17. Jeong, S.I., et al., Subcutaneous panniculitis-like T-cell lymphoma of the breast. Korean J Radiol, 2013. 14(3): p. 391-4.
18. Puchi Silva, A., et al., [Paniculitis as manifestation of prolonged febrile syndrome: Case report]. Rev Chil Pediatr, 2017. 88(3): p. 398-403.
19. James, W.D., Elston, D. M., Berger, T. G., & Andrews, G. C. , Andrews’ Disease of the skin: Clinical dermatology. 2011, London: Saunders/Elsevier.
20. Asati, D.P., et al., Subcutaneous panniculitis-like T-cell lymphoma with macrophage activation syndrome treated by cyclosporine and prednisolone. Indian Dermatol Online J, 2016. 7(6): p. 529-532.
21. Kosari, F. and S. Akbarzadeh Hosseini, Local facial edema: a novel presentation of subcutaneous panniculitis-like T-cell lymphoma in a 30-year-old Iranian woman. Acta Med Iran, 2014. 52(12): p. 950-3.
22. Koh, M.J., et al., Aggressive subcutaneous panniculitis-like T-cell lymphoma with hemophagocytosis in two children (subcutaneous panniculitis-like T-cell lymphoma). J Am Acad Dermatol, 2009. 61(5): p. 875-81.
23. Jung, H.R., et al., Cyclosporine in Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma after Autologous Hematopoietic Stem Cell Transplantation. Cancer Res Treat, 2011. 43(4): p. 255-9.
24. Sy, A.N., T.P. Lam, and U.S. Khoo, Subcutaneous panniculitislike T-cell lymphoma appearing as a breast mass: a difficult and challenging case appearing at an unusual site. J Ultrasound Med, 2005. 24(10): p. 1453-60.
25. Bosisio, F., et al., Lobular panniculitic infiltrates with overlapping histopathologic features of lupus panniculitis (lupus profundus) and subcutaneous T-cell lymphoma: a conceptual and practical dilemma. Am J Surg Pathol, 2015. 39(2): p. 206-11.
26. Rojnuckarin, P., et al., Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma. Leuk Lymphoma, 2007. 48(3): p. 560-3.
27. Hu, Z.L., et al., Subcutaneous Panniculitis-Like T-Cell Lymphoma in Children: A Review of the Literature. Pediatr Dermatol, 2015. 32(4): p. 526-32.
28. Lee, W.S., et al., Cyclosporine A as a Primary Treatment for Panniculitis-like T Cell Lymphoma: A Case with a Long-Term Remission. Cancer Res Treat, 2014. 46(3): p. 312-6.
29. West, E.S., et al., Remission of subcutaneous panniculitis-like T-cell lymphoma in a pregnant woman after treatment with oral corticosteroids as monotherapy. JAAD Case Rep, 2017. 3(2): p. 87-89.
30. Ichii, M., et al., Successful treatment of refractory subcutaneous panniculitis-like T-cell lymphoma with allogeneic peripheral blood stem cell transplantation from HLA-mismatched sibling donor. Leuk Lymphoma, 2006. 47(10): p. 2250-2.
31. Dholaria, B., et al., Relapsed subcutaneous panniculitis-like T cell lymphoma: role of haploidentical hematopoietic stem cell transplant. Ann Hematol, 2017. 96(12): p. 2125-2126.